What does CUSIP 65343E108 represent in this 13F holders report?

CUSIP 65343E108 is the security identifier for NXTC - NextCure, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

How many institutions held NXTC - NextCure, Inc. - Common Stock, par value $0.001 per share in Q2 2020?

87 institutional investors reported NXTC - NextCure, Inc. - Common Stock, par value $0.001 per share for Q2 2020. Use the holders table for investor-level position and value details.

NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC)

CUSIP: 65343E108

Q2 2020 13F Holders as of 30 Jun 2020

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 20,244,521
Total 13F value: $434,046,210
Share change: +44,782
Put/Call ratio: 298%
SEC-reported price per share: $21.44
Number of holders: 87
Value change: -$4,189,870
Number of buys: 61
Number of sells: 30
Shares outstanding: 3,602,511

Security key

65343E108

Report period

Q2 2020

Institutions

Top holders

NXTC full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 NextCure, Inc. SEC filings NextCure, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 65343E108

Newer quarter: Q3 2025

Recent filing periods:

Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of NXTC - NextCure, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ORBIMED ADVISORS LLC

Disclosed value leader

ORBIMED ADVISORS LLC

Comparable rows

0/15

Latest evidence

31 Mar 2020

13F Highest disclosed value: $100,497,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $100.5M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.

Disclosed position value Top 5

ORBIMED ADVISORS LLC $100.5M

Sofinnova Investments, Inc. $99.05M

LORD, ABBETT & CO. LLC $79.23M

Canaan Partners X LLC $75.19M

GREAT POINT PARTNERS LLC $48.67M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORBIMED ADVISORS LLC	13F Company 13F	— denominator unverified	$100,497,000 2,711,013 shares	—	31 Mar 2020
Sofinnova Investments, Inc.	13F Company 13F	— denominator unverified	$99,046,000 2,671,856 shares	—	31 Mar 2020
LORD, ABBETT & CO. LLC	13F Company 13F	— denominator unverified	$79,231,000 2,137,346 shares	—	31 Mar 2020
Canaan Partners X LLC	13F Company 13F	— denominator unverified	$75,194,000 2,028,442 shares	—	31 Mar 2020
GREAT POINT PARTNERS LLC	13F Company 13F	— denominator unverified	$48,671,000 1,312,956 shares	—	31 Mar 2020
ALLIANCEBERNSTEIN L.P.	13F Company 13F	— denominator unverified	$46,488,000 1,254,047 shares	—	31 Mar 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

20,244,521

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2020 vs Q3 2025 Across Filers

Q3 2025 holders

Q2 2020 holders

Holder diff

Investor	Q3 2025 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q3 2025 value	Q2 2020 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend